Università di Ferrara - Tecnopolo Universtità di Ferrara Universtità di Ferrara
 

     
 

Tariffario

 
     
[ Italiano | English ]

Pubblicazioni

  • Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, (2014) Ivabradine in stable coronary artery disease without clinical heart failure. N. Engl. J. Med. 371:1091-9. PubMed
  • Fortini C, Cesselli D, Beltrami AP, Bergamin N, Caragnano A, Moretti L, Cecaro F, Aquila G, Rizzo P, Riberti C, Tavazzi L, Fucili A, Beltrami CA, Ferrari R (2014) Alteration of Notch signaling and functionality of adipose tissue derived mesenchymal stem cells in heart failure. Int. J. Cardiol. 174:119-26. PubMed
  • Ferrari R, Rizzo P (2014) The Notch pathway: a novel target for myocardial remodelling therapy? Eur. Heart J. 35:2140-5. PubMed
  • Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, Dorian P, Hu D, Shalnova S, Sokn FJ, Ford I, Fox KM, (2014) Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med 174:1651-9. PubMed
  • Caliceti C, Aquila G, Pannella M, Morelli MB, Fortini C, Pinton P, Bonora M, Hrelia S, Pannuti A, Miele L, Rizzo P, Ferrari R (2013) 17β-estradiol enhances signalling mediated by VEGF-A-delta-like ligand 4-notch1 axis in human endothelial cells. PLoS ONE 8:e71440. PubMed
  • Valgimigli M, Campo G, Percoco G, Bolognese L, Vassanelli C, Colangelo S, de Cesare N, Rodriguez AE, Ferrario M, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro MS, Parrinello G, Ferrari R, (2008) Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 299:1788-99. PubMed
  • Fox K, Ford I, Steg PG, Tendera M, Ferrari R, (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807-16. PubMed
  • Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817-21. PubMed
 
ASTER Por-Fesr Universtità di Ferrara